Home›Search›Onkologie (Czech Republic)

Onkologie (Czech Republic)

SOLEN s.r.o. · Czech Republic · Est. 2016

ISSN1802-4475

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.116

H-Indexi

SNIPi

0.016

Total Worksi

592

Total Citationsi

216

2yr Mean Citednessi

0.05

Open Impact Factor alternative

Aims & Scope

Subject areas: Cancer Research; Medicine (miscellaneous); Oncology.

General Information

Country / RegionCzech Republic

Primary Language—

1st Year Published2016

Annual Volume~ 62 articles / year

StatusActive (last: 2025)

Total Publications592

Publisher OrgSolen s.r.o.

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

SOLEN s.r.o.

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

1802-4475

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ4

Medicine (miscellaneous)Q4

OncologyQ4

Subject Classification

Scopus Categories

Cancer ResearchOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLymphoma Diagnosis and TreatmentColorectal Cancer Treatments and StudiesGastric Cancer Management and OutcomesOvarian cancer diagnosis and treatmentLung Cancer Research StudiesRenal cell carcinoma treatmentBreast Cancer Treatment StudiesEndometrial and Cervical Cancer Treatments

Frequently asked questions about Onkologie (Czech Republic)

Is Onkologie (Czech Republic) a predatory journal?

PubScope has no integrity flags on record for Onkologie (Czech Republic): it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Onkologie (Czech Republic)?

Onkologie (Czech Republic) is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.116.

Is Onkologie (Czech Republic) indexed in Scopus and Web of Science?

Onkologie (Czech Republic) is indexed in Scopus.

What is the aims and scope of Onkologie (Czech Republic)?